Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IVVD Invivyd, Inc.

交易中 02-11 15:00:23 EST

1.61

-0.02

-1.23%

最高1.67	最低1.52	成交量219.13万
今开1.67	昨收1.63	日振幅9.51%
总市值4.54亿	流通市值3.28亿	总股本2.82亿
成交额342.23万	换手率1.07%	流通股本2.04亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IVVD","market":"US","secType":"STK","nameCN":"Invivyd, Inc.","latestPrice":1.61,"timestamp":1770840022525,"preClose":1.63,"halted":0,"volume":2191312,"delay":0,"changeRate":-0.012269938650306624,"floatShares":204000000,"shares":282000000,"eps":-0.451489,"marketStatus":"交易中","change":-0.02,"latestTime":"02-11 15:00:23 EST","open":1.67,"high":1.67,"low":1.515,"amount":3422342.4344736,"amplitude":0.095092,"askPrice":1.61,"askSize":2472,"bidPrice":1.6,"bidSize":2978,"shortable":3,"etf":0,"ttmEps":-0.451489,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":1.63,"preHourTrading":{"tag":"盘前","latestPrice":1.69,"preClose":1.63,"latestTime":"09:29 EST","volume":57432,"amount":97205.27958239999,"timestamp":1770820199999,"change":0.06,"changeRate":0.03681,"amplitude":0.058405},"postHourTrading":{"tag":"盘后","latestPrice":1.6106,"preClose":1.63,"latestTime":"19:52 EST","volume":10702,"amount":17361.3902,"timestamp":1770771169280,"change":-0.0194,"changeRate":-0.011902,"amplitude":0.01227},"volumeRatio":0.608413,"impliedVol":0.9381,"impliedVolPercentile":0.239},"requestUrl":"/m/hq/s/IVVD/tweets","defaultTab":"tweets","newsList":[{"id":"2609516039","title":"Invivyd, Inc.盘中异动 股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609516039","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609516039?lang=zh_cn&edition=full","pubTime":"2026-02-07 01:54","pubTimestamp":1770400492,"startTime":"0","endTime":"0","summary":"北京时间2026年02月07日01时54分，Invivyd, Inc.股票出现波动，股价大幅下跌5.56%。截至发稿，该股报1.62美元/股，成交量350.453万股，换手率1.24%，振幅9.94%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为1.40%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207015452a4858f3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207015452a4858f3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","IVVD","BK4139"],"gpt_icon":0},{"id":"1198810666","title":"Invivyd与美国FDA就Liberty三期试验达成一致，将评估VYD2311抗体对比mRNA新冠疫苗安全性并探索抗体与疫苗联合使用的安全性与免疫学特征","url":"https://stock-news.laohu8.com/highlight/detail?id=1198810666","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198810666?lang=zh_cn&edition=full","pubTime":"2026-02-03 20:02","pubTimestamp":1770120135,"startTime":"0","endTime":"0","summary":"Invivyd公司已与美国食品药品监督管理局就Liberty三期临床试验方案达成共识。该试验旨在评估其研发的VYD2311抗体药物与mRNA新冠疫苗在安全性方面的对比数据，同时系统研究抗体与疫苗联合给药时的安全性和免疫学反应特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVVD","BK4539"],"gpt_icon":0},{"id":"2603866899","title":"Invivyd, Inc.盘中异动 早盘股价大跌5.10%报2.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603866899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603866899?lang=zh_cn&edition=full","pubTime":"2026-01-14 00:25","pubTimestamp":1768321550,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日00时25分，Invivyd, Inc.股票出现异动，股价大幅下挫5.10%。截至发稿，该股报2.33美元/股，成交量109.826万股，换手率0.39%，振幅8.56%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114002550a4bf9ab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114002550a4bf9ab0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD","BK4539"],"gpt_icon":0},{"id":"2601768888","title":"Invivyd, Inc.盘中异动 股价大跌5.10%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601768888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601768888?lang=zh_cn&edition=full","pubTime":"2026-01-07 01:42","pubTimestamp":1767721342,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日01时42分，Invivyd, Inc.股票出现波动，股价快速下挫5.10%。截至发稿，该股报2.42美元/股，成交量102.915万股，换手率0.37%，振幅6.47%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107014223a6fb3dea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107014223a6fb3dea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4539","BK4139"],"gpt_icon":0},{"id":"2601421869","title":"Invivyd, Inc.盘中异动 早盘股价大跌5.20%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601421869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601421869?lang=zh_cn&edition=full","pubTime":"2026-01-05 23:34","pubTimestamp":1767627266,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日23时34分，Invivyd, Inc.股票出现异动，股价大幅跳水5.20%。截至发稿，该股报2.37美元/股，成交量86.8487万股，换手率0.31%，振幅6.80%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为1.88%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105233426953c056c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105233426953c056c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","IVVD","BK4139"],"gpt_icon":0},{"id":"1161114265","title":"Invivyd宣布启动Declaration临床试验，这是针对Vyd2311的第三阶段安慰剂对照关键研究，一种用于预防Covid的疫苗替代抗体","url":"https://stock-news.laohu8.com/highlight/detail?id=1161114265","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161114265?lang=zh_cn&edition=full","pubTime":"2025-12-23 20:03","pubTimestamp":1766491396,"startTime":"0","endTime":"0","summary":"Invivyd宣布启动Declaration临床试验，这是针对Vyd2311的第三阶段安慰剂对照关键研究，一种用于预防Covid的疫苗替代抗体","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVVD","BK4539"],"gpt_icon":0},{"id":"2586089304","title":"Invivyd, Inc.盘中异动 急速跳水5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586089304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586089304?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:30","pubTimestamp":1764081051,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日22时30分，Invivyd, Inc.股票出现异动，股价大幅下挫5.42%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Pharmacyte  Biotech, Inc.、Anavex Life Sciences Corp.涨幅较大，Clearmind Medicine Inc.、Lunai Bioworks Inc.、Pasithea Therapeutics Corp.较为活跃，换手率分别为204.03%、126.16%、18.79%，振幅较大的相关个股有Pharmacyte  Biotech, Inc.、Anavex Life Sciences Corp.、Cardio Diagnostics Holdings Inc.，振幅分别为12.15%、7.95%、6.92%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125223051a4b9b074&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125223051a4b9b074&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"1134589274","title":"Invivyd宣布选定潜在的一流RSV抗体候选药物Vby329；目标为2026年下半年IND准备就绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1134589274","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134589274?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:02","pubTimestamp":1763985764,"startTime":"0","endTime":"0","summary":"Invivyd宣布选定潜在的一流RSV抗体候选药物Vby329；目标为2026年下半年IND准备就绪","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVVD","BK4539"],"gpt_icon":0},{"id":"1191384298","title":"Invivyd 第三季度每股收益为 -0.06 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191384298","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191384298?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:57","pubTimestamp":1763571449,"startTime":"0","endTime":"0","summary":"11月6日 - Invivyd 第三季度收入为 1312.9 万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IVVD","BK4139"],"gpt_icon":0},{"id":"1172620322","title":"Invivyd第三季度每股收益为-0.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172620322","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172620322?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:16","pubTimestamp":1762431395,"startTime":"0","endTime":"0","summary":"11月6日 - Invivyd第三季度营收为1312.9万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"1117108328","title":"Invivyd宣布获得美国IND批准，并与美国FDA就预防新冠疫苗替代抗体Vyd2311的关键临床项目达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1117108328","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117108328?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:03","pubTimestamp":1759748601,"startTime":"0","endTime":"0","summary":"Invivyd宣布获得美国IND批准，并与美国FDA就预防新冠疫苗替代抗体Vyd2311的关键临床项目达成一致","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVVD","BK4539"],"gpt_icon":0},{"id":"1148205802","title":"Invivyd Inc：Declaration和Liberty临床试验预计2025年底启动，主要数据预期2026年中期公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1148205802","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148205802?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:03","pubTimestamp":1759748588,"startTime":"0","endTime":"0","summary":"Invivyd Inc宣布，公司的Declaration和Liberty临床试验计划在2025年底前后开始进行。该公司预计相关试验的主要临床数据将在2026年中期对外公布。\n这两项临床试验的启动标志着Invivyd Inc在其研发管线推进方面的重要里程碑，市场将密切关注试验进展及后续数据发布情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","IVVD"],"gpt_icon":0},{"id":"1193586295","title":"Invivyd, Inc.任命Paul B. Bolno医学博士为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1193586295","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193586295?lang=zh_cn&edition=full","pubTime":"2025-09-25 06:33","pubTimestamp":1758753216,"startTime":"0","endTime":"0","summary":"9月24日消息，Invivyd, Inc.宣布任命Paul B. Bolno医学博士为公司董事会成员。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4539","BK4139"],"gpt_icon":0},{"id":"2568428548","title":"Invivyd, Inc.盘中异动 下午盘快速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568428548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568428548?lang=zh_cn&edition=full","pubTime":"2025-09-18 02:44","pubTimestamp":1758134671,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日02时44分，Invivyd, Inc.股票出现异动，股价大幅下跌5.16%。截至发稿，该股报1.20美元/股，成交量98.0307万股，换手率0.47%，振幅6.26%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509180244319534a212&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509180244319534a212&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD","BK4539"],"gpt_icon":0},{"id":"2567018301","title":"Invivyd, Inc.盘中异动 早盘急速下跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567018301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567018301?lang=zh_cn&edition=full","pubTime":"2025-09-15 21:36","pubTimestamp":1757943374,"startTime":"0","endTime":"0","summary":"北京时间2025年09月15日21时36分，Invivyd, Inc.股票出现波动，股价快速跳水5.59%。截至发稿，该股报1.35美元/股，成交量40.2047万股，换手率0.19%，振幅3.19%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915213615a4c79024&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915213615a4c79024&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4539","BK4139"],"gpt_icon":0},{"id":"2561496135","title":"美股周四早盘生物制药公司Invivyd（IVVD）股价重挫18%%此前该公司宣布通过证券发行筹集5000万美元资金。这笔","url":"https://stock-news.laohu8.com/highlight/detail?id=2561496135","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561496135?lang=zh_cn&edition=full","pubTime":"2025-08-21 22:12","pubTimestamp":1755785542,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","IVVD","BK4539","161027"],"gpt_icon":0},{"id":"2561648211","title":"Invivyd, Inc.盘中异动 早盘快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561648211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561648211?lang=zh_cn&edition=full","pubTime":"2025-08-20 23:21","pubTimestamp":1755703262,"startTime":"0","endTime":"0","summary":"北京时间2025年08月20日23时21分，Invivyd, Inc.股票出现波动，股价急速拉升5.08%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Tharimmune, Inc.、Novabay Pharmaceuticals, Inc.、Propanc Biopharma, Inc.涨幅较大，Tharimmune, Inc.、Novabay Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为3182.31%、2408.68%、345.68%，振幅较大的相关个股有Tharimmune, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Novabay Pharmaceuticals, Inc.，振幅分别为133.33%、100.00%、50.02%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820232102a4944c9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820232102a4944c9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4539","BK4139"],"gpt_icon":0},{"id":"2558667463","title":"Invivyd, Inc.盘中异动 股价大跌5.14%报0.757美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558667463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558667463?lang=zh_cn&edition=full","pubTime":"2025-08-12 02:43","pubTimestamp":1754937803,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日02时43分，Invivyd, Inc.股票出现波动，股价大幅下跌5.14%。截至发稿，该股报0.757美元/股，成交量36.3305万股，换手率0.30%，振幅6.44%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081202432394dd2fd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081202432394dd2fd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","IVVD"],"gpt_icon":0},{"id":"2518271809","title":"Invivyd, Inc.盘中异动 早盘快速跳水5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518271809?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:09","pubTimestamp":1741619349,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时09分，Invivyd, Inc.股票出现波动，股价大幅下挫5.59%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3551.71%、926.79%、795.06%，振幅较大的相关个股有Scisparc Ltd.、Aeon Biopharma, Inc.、Dogwood Therapeutics, Inc.，振幅分别为49.87%、41.96%、41.36%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230909a26a4960&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230909a26a4960&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2517161369","title":"Invivyd, Inc.盘中异动 快速跳水5.86%报0.998美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161369?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:00","pubTimestamp":1741273241,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时00分，Invivyd, Inc.股票出现波动，股价快速跳水5.86%。截至发稿，该股报0.998美元/股，成交量26.2609万股，换手率0.22%，振幅2.83%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230042963c5360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230042963c5360&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.invivyd.com","stockEarnings":[{"period":"1week","weight":-0.133},{"period":"1month","weight":-0.3532},{"period":"3month","weight":-0.0791},{"period":"6month","weight":1.0393},{"period":"1year","weight":0.0382},{"period":"ytd","weight":-0.3401}],"compareEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":-0.0028},{"period":"3month","weight":0.0128},{"period":"6month","weight":0.0731},{"period":"1year","weight":0.1443},{"period":"ytd","weight":0.015}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Invivyd, Inc.于2020年6月3日在特拉华州成立。该公司是一家处于商业阶段的公司，其使命是快速、永久地提供基于抗体的疗法，以保护脆弱人群免受流行病毒威胁的破坏性后果，从SARS-CoV-2开始。该公司专有的INVYMAB平台方法将最先进的病毒监测和预测建模与先进的抗体工程相结合。INVYMAB旨在促进快速、连续产生新的单克隆抗体（“MAB”），以跟上不断演变的病毒威胁。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.046272},{"month":2,"riseRate":0.2,"avgChangeRate":0.339707},{"month":3,"riseRate":0.25,"avgChangeRate":-0.244287},{"month":4,"riseRate":0.25,"avgChangeRate":-0.228751},{"month":5,"riseRate":0.75,"avgChangeRate":0.245954},{"month":6,"riseRate":0.25,"avgChangeRate":-0.236507},{"month":7,"riseRate":0.75,"avgChangeRate":0.147422},{"month":8,"riseRate":0.75,"avgChangeRate":0.158597},{"month":9,"riseRate":0.6,"avgChangeRate":0.03577},{"month":10,"riseRate":0.4,"avgChangeRate":0.071726},{"month":11,"riseRate":0.4,"avgChangeRate":0.062538},{"month":12,"riseRate":0.4,"avgChangeRate":0.008789}],"exchange":"NASDAQ","name":"Invivyd, Inc.","nameEN":"Invivyd, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Invivyd, Inc.(IVVD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Invivyd, Inc.,IVVD,Invivyd, Inc.股票,Invivyd, Inc.股票老虎,Invivyd, Inc.股票老虎国际,Invivyd, Inc.行情,Invivyd, Inc.股票行情,Invivyd, Inc.股价,Invivyd, Inc.股市,Invivyd, Inc.股票价格,Invivyd, Inc.股票交易,Invivyd, Inc.股票购买,Invivyd, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Invivyd, Inc.(IVVD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}